Sheila Gujrathi - Oct 25, 2021 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Director
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Oct 25, 2021
Transactions value $
$0
Form type
4
Date filed
10/25/2021, 06:45 PM
Previous filing
Oct 20, 2021
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Conversion of derivative security $0 +32.9K $0.00 32.9K Oct 25, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTYX Series A Preferred Stock Conversion of derivative security $0 -32.9K -100% $0.00* 0 Oct 25, 2021 Common Stock 32.9K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares of the preferred stock, par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.